Influenza Vaccination and Hospitalization Outcomes Among Older Patients With Cardiovascular or Respiratory Diseases

Author:

Pang Yuanjie1ORCID,Wang Qi23,Lv Min4,Yu Mengke3,Lu Ming5,Huang Yangmu3,Wu Jiang4,Xie Zheng3

Affiliation:

1. Department of Epidemiology and Biostatistics, School of Public Health, Peking University Health Science Center, Beijing, China

2. Hospital Service Management Office, Peking University Third Hospital, Beijing, China

3. Department of Global Health, School of Public Health, Peking University Health Science Center, Beijing, China

4. Institute for Immunization and Prevention, Beijing Center for Disease Prevention and Control, Beijing, China

5. Department of Biomedical Informatics, School of Basic Medicine, Peking University Health Science Center, Beijing, China

Abstract

Abstract Background Influenza vaccination has been suggested to protect against death and recurrent events among patients with cardiovascular disease or chronic obstructive respiratory disease, but there is limited evidence in older adults, who have higher risks of influenza-associated hospitalization and mortality. Methods Patients aged ≥60 years hospitalized for cardiovascular or respiratory diseases from the Beijing Urban Employee Basic Medical Insurance database during 3 influenza seasons (2013–2014 through 2015–2016) were pooled to estimate the effects of influenza vaccination on hospitalization outcomes. Vaccination status was ascertained through cross-referencing the Beijing Elderly Influenza Vaccination database. The summer months (June–August) were used as a reference period to adjust for unmeasured confounders during influenza seasons. Results After adjustment for both measured and unmeasured confounders, influenza vaccination was associated with lower risks of in-hospital deaths among patients hospitalized for cardiovascular (odds ratio [95% confidence interval], 0.85 [.68–1.06]) or respiratory diseases (0.66 [.54–.82]). Influenza vaccination was associated with a lower risk of readmission among patients with cardiovascular (odds ratio [95% confidence interval], 0.81 [.69–.95]) but not respiratory diseases (1.12 [.92–1.35]). Influenza vaccination was also associated with lower direct medical costs, but not with length of stay. Conclusions Influenza vaccination protected against hospitalization outcomes among older adults with cardiovascular or respiratory diseases.

Funder

Beijing Municipal Health Commission, Pilot Projects of Public Welfare, Development and Reform

Medical Research Institutes

China Postdoctoral Science Foundation

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Immunology and Allergy

Reference28 articles.

1. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017;Global Burden of Disease Causes of Death Collaborators;Lancet,2018

2. Mortality, morbidity, and hospitalisations due to influenza lower respiratory tract infections, 2017: an analysis for the Global Burden of Disease Study 2017;Global Burden of Disease Influenza Collaborators;Lancet Respir Med,2019

3. Vaccines for preventing influenza in the elderly;Demicheli;Cochrane Database Syst Rev,2018

4. Influenza vaccines for preventing cardiovascular disease;Clar;Cochrane Database Syst Rev,2015

5. Influenza but not pneumococcal vaccination protects against all-cause mortality in patients with COPD;Schembri;Thorax,2009

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3